Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Degludec Formulations vs Glargine in T2DM
NCT00611884Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Jan 2008
- Primary completion
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of insulin degludec in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Jan 2008; status: completed.
02
Drugs
insulin degludec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00611884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00611884.